Walleye Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,300
Closed -$87.5K 4360
2025
Q4
$87.5K Buy
+1,300
New +$87.4K ﹤0.01% 3794
2025
Q3
Sell
-300
Closed -$15.6K 4559
2025
Q2
$15.6K Sell
300
-400
-57% -$22.8K ﹤0.01% 3997
2025
Q1
$44.7K Buy
+700
New +$40.7K ﹤0.01% 3639
2024
Q4
Sell
-10,600
Closed -$607K 4400
2024
Q3
$607K Buy
+10,600
New +$608K ﹤0.01% 2398
2024
Q1
Sell
-3,000
Closed -$111K 5003
2023
Q4
$111K Hold
3,000
﹤0.01% 4105
2023
Q3
$115K Buy
+3,000
New +$123K ﹤0.01% 3904
2023
Q1
Sell
-52,700
Closed -$3M 5051
2022
Q4
$3M Buy
52,700
+40,700
+339% +$2.08M 0.01% 1405
2022
Q3
$474K Buy
12,000
+9,400
+362% +$415K ﹤0.01% 2962
2022
Q2
$114K Buy
2,600
+200
+8% +$8.65K ﹤0.01% 4064
2022
Q1
$96K Sell
2,400
-4,200
-64% -$150K ﹤0.01% 4264
2021
Q4
$265K Buy
6,600
+4,300
+187% +$161K ﹤0.01% 3609
2021
Q3
$94K Buy
+2,300
New +$96.2K ﹤0.01% 4395
2021
Q2
Sell
-11,900
Closed -$496K 5316
2021
Q1
$496K Sell
11,900
-3,600
-23% -$164K ﹤0.01% 2665
2020
Q4
$662K Buy
15,500
+2,200
+17% +$79.1K ﹤0.01% 2407
2020
Q3
$350K Sell
13,300
-6,100
-31% -$170K ﹤0.01% 2550
2020
Q2
$520K Hold
19,400
﹤0.01% 2259
2020
Q1
$349K Buy
19,400
+19,200
+9,600% +$364K ﹤0.01% 2175
2019
Q4
$4K Sell
200
-9,000
-98% -$156K ﹤0.01% 4122
2019
Q3
$143K Buy
9,200
+5,700
+163% +$93.9K ﹤0.01% 3146
2019
Q2
$60K Buy
+3,500
New +$56.5K ﹤0.01% 3477
2018
Q3
Sell
-15,200
Closed -$256K 5382
2018
Q2
$256K Buy
+15,200
New +$287K ﹤0.01% 3425

Other funds holding HALO

Walleye Trading's HALO Position: Q2 2025 in Review

Walleye Trading sold out of Halozyme (HALO) in Q2 2025, closing a stake of 2,366 shares — an estimated $135K sold.

Walleye Trading first reported a position in HALO in Q2 2015 and held it in 18 quarters. The position peaked at $2.05M in Q4 2022. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Walleye Trading reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 2,366 Halozyme shares in Q2 2025, an estimated $135K.
  • Walleye Trading first reported a position in Halozyme in Q2 2015 and held it in 18 quarters.
  • Walleye Trading's Halozyme position peaked at $2.05M in Q4 2022.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.